Metabolic alterations and vulnerabilities in hepatocellular carcinoma

被引:49
作者
Tenen, Daniel G. [1 ,2 ]
Chai, Li [3 ]
Tan, Justin L. [1 ,4 ,5 ]
机构
[1] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore
[2] Harvard Med Sch, Harvard Stem Cell Inst, Boston, MA 02115 USA
[3] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[4] ASTAR, Expt Drug Dev Ctr, 10 Biopolis Rd, Singapore 138670, Singapore
[5] ASTAR, Genome Inst Singapore, Singapore, Singapore
基金
美国国家卫生研究院; 英国医学研究理事会;
关键词
hepatocellular carcinoma (HCC); metabolism; metabolic vulnerability; targeted therapy; FATTY LIVER-DISEASE; MITOCHONDRIAL OXIDATIVE-PHOSPHORYLATION; PENTOSE-PHOSPHATE PATHWAY; RAT PYRUVATE-KINASE; O-GLCNACYLATION; STATIN USE; IN-VITRO; NONALCOHOLIC STEATOHEPATITIS; SUCCINATE-DEHYDROGENASE; GLUTAMINE-SYNTHETASE;
D O I
10.1093/gastro/goaa066
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Liver cancer is a serious disease. It is ranked as the cancer with the second highest number of cancer-related deaths worldwide. Hepatocellular carcinoma (HCC), which arises from transformed hepatocytes, is the major subtype of liver cancer. It accounts for 85% of total liver-cancer cases. An important aspect of HCC that has been actively studied is its metabolism. With the liver as the primary site of numerous metabolic processes in the body, it has been shown that the metabolism of HCC cells is highly dysregulated compared to that of normal hepatocytes. It is therefore crucial to understand the metabolic alterations caused by HCC and the underlying mechanisms for these alterations. This deeper understanding will allow diagnostic and therapeutic advancements in the treatment of HCC. In this review, we will summarize the current literature in HCC metabolic alterations, induced vulnerabilities, and potential therapeutic interventions.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 135 条
[1]   Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma [J].
Abou-Alfa, G. K. ;
Qin, S. ;
Ryoo, B-Y. ;
Lu, S-N. ;
Yen, C-J. ;
Feng, Y-H. ;
Lim, H. Y. ;
Izzo, F. ;
Colombo, M. ;
Sarker, D. ;
Bolondi, L. ;
Vaccaro, G. ;
Harris, W. P. ;
Chen, Z. ;
Hubner, R. A. ;
Meyer, T. ;
Sun, W. ;
Harding, J. J. ;
Hollywood, E. M. ;
Ma, J. ;
Wan, P. J. ;
Ly, M. ;
Bomalaski, J. ;
Johnston, A. ;
Lin, C-C. ;
Chao, Y. ;
Chen, L-T. .
ANNALS OF ONCOLOGY, 2018, 29 (06) :1402-1408
[2]   Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma [J].
Ally, Adrian ;
Balasundaram, Miruna ;
Carlsen, Rebecca ;
Chuah, Eric ;
Clarke, Amanda ;
Dhalla, Noreen ;
Holt, Robert A. ;
Jones, Steven J. M. ;
Lee, Darlene ;
Ma, Yussanne ;
Marra, Marco A. ;
Mayo, Michael ;
Moore, Richard A. ;
Mungall, Andrew J. ;
Schein, Jacqueline E. ;
Sipahimalani, Payal ;
Tam, Angela ;
Thiessen, Nina ;
Cheung, Dorothy ;
Wong, Tina ;
Brooks, Denise ;
Robertson, A. Gordon ;
Bowlby, Reanne ;
Mungall, Karen ;
Sadeghi, Sara ;
Xi, Liu ;
Covington, Kyle ;
Shinbrot, Eve ;
Wheeler, David A. ;
Gibbs, Richard A. ;
Donehower, Lawrence A. ;
Wang, Linghua ;
Bowen, Jay ;
Gastier-Foster, Julie M. ;
Gerken, Mark ;
Helsel, Carmen ;
Leraas, Kristen M. ;
Lichtenberg, Tara M. ;
Ramirez, Nilsa C. ;
Wise, Lisa ;
Zmuda, Erik ;
Gabriel, Stacey B. ;
Meyerson, Matthew ;
Cibulskis, Carrie ;
Murray, Bradley A. ;
Shih, Juliann ;
Beroukhim, Rameen ;
Cherniack, Andrew D. ;
Schumacher, Steven E. ;
Saksena, Gordon .
CELL, 2017, 169 (07) :1327-+
[3]   GLUT1 Expression Is Increased in Hepatocellular Carcinoma and Promotes Tumorigenesis [J].
Amann, Thomas ;
Maegdefrau, Ulrike ;
Hartmann, Arndt ;
Agaimy, Abbas ;
Marienhagen, Joerg ;
Weiss, Thomas S. ;
Stoeltzing, Oliver ;
Warnecke, Christina ;
Schoelmerich, Juergen ;
Oefner, Peter J. ;
Kreutz, Marina ;
Bosserhoff, Anja K. ;
Hellerbrand, Claus .
AMERICAN JOURNAL OF PATHOLOGY, 2009, 174 (04) :1544-1552
[4]   Histological Assessment of NAFLD [J].
Bedossa, Pierre .
DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (05) :1348-1355
[5]  
Bray F., 2018, CA-CANCER J CLIN, V68, P394, DOI DOI 10.3322/caac.21492
[6]   Integrated Metabolite and Gene Expression Profiles Identify Lipid Biomarkers Associated With Progression of Hepatocellular Carcinoma and Patient Outcomes [J].
Budhu, Anuradha ;
Roessler, Stephanie ;
Zhao, Xuelian ;
Yu, Zhipeng ;
Forgues, Marshonna ;
Ji, Junfang ;
Karoly, Edward ;
Qin, Lun-Xiu ;
Ye, Qing-Hai ;
Jia, Hu-Liang ;
Fan, Jia ;
Sun, Hui-Chuan ;
Tang, Zhao-You ;
Wang, Xin Wei .
GASTROENTEROLOGY, 2013, 144 (05) :1066-+
[7]   Increased Lipogenesis, Induced by AKT-mTORC1-RPS6 Signaling, Promotes Development of Human Hepatocellular Carcinoma [J].
Calvisi, Diego F. ;
Wang, Chunmei ;
Ho, Coral ;
Ladu, Sara ;
Lee, Susie A. ;
Mattu, Sandra ;
Destefanis, Giulia ;
Delogu, Salvatore ;
Zimmermann, Antje ;
Ericsson, Johan ;
Brozzetti, Stefania ;
Staniscia, Tommaso ;
Chen, Xin ;
Dombrowski, Frank ;
Evert, Matthias .
GASTROENTEROLOGY, 2011, 140 (03) :1071-U542
[8]   O-GlcNAc transferase activates stem-like cell potential in hepatocarcinoma through O-GlcNAcylation of eukaryotic initiation factor 4E [J].
Cao, Benjin ;
Duan, Meng ;
Xing, Yang ;
Liu, Chanjuan ;
Yang, Fan ;
Li, Yinan ;
Yang, Tianxiao ;
Wei, Yuanyan ;
Gao, Qiang ;
Jiang, Jianhai .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (04) :2384-2398
[9]   A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma [J].
Chaerkady, Raghothama ;
Harsha, H. C. ;
Nalli, Anuradha ;
Gucek, Marjan ;
Vivekanandan, Perumal ;
Akhtar, Javed ;
Cole, Robert N. ;
Simmers, Jessica ;
Schulick, Richard D. ;
Singh, Sujay ;
Torbenson, Michael ;
Pandey, Akhilesh ;
Thuluvath, Paul J. .
JOURNAL OF PROTEOME RESEARCH, 2008, 7 (10) :4289-4298
[10]   The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases [J].
Chalasani, Naga ;
Younossi, Zobair ;
Lavine, Joel E. ;
Charlton, Michael ;
Cusi, Kenneth ;
Rinella, Mary ;
Harrison, Stephen A. ;
Brunt, Elizabeth M. ;
Sanyal, Arun J. .
HEPATOLOGY, 2018, 67 (01) :328-357